Danielle Elizabeth DETTLING

Follow

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies specific for FLT3 and their uses
- Patent number 12,202,910
- Issue date Jan 21, 2025
- PFIZER INC.
- Danielle Elizabeth Dettling
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for FLT3 and their uses
- Patent number 11,421,040
- Issue date Aug 23, 2022
- Pfizer Inc.
- Danielle Elizabeth Dettling
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20240026011
- Publication date Jan 25, 2024
- Takeda Pharmaceutical Company Limited
- Robert B. DuBridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20230340159
- Publication date Oct 26, 2023
- Takeda Pharmaceutical Company Limited
- Robert B. DuBridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING FLT3
- Publication number 20230181634
- Publication date Jun 15, 2023
- Pfizer Inc.
- Barbra Johnson SASU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR FLT3 AND THEIR USES
- Publication number 20230059489
- Publication date Feb 23, 2023
- Pfizer Inc.
- Danielle Elizabeth DETTLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR FLT3 AND THEIR USES
- Publication number 20180346601
- Publication date Dec 6, 2018
- Pfizer Inc.
- Danielle Elizabeth DETTLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE